Vogenx awards William Wilkison 155,000 stock options

The chief scientific officer's options vest in three annual installments, subject to continued service through each vesting date.

Rhea-AI Filing Summary

Vogenx, Inc. (VOGX) Chief Scientific Officer, director and 10% owner William Wilkison received an option award covering 155,000 shares of common stock, with an exercise price of $20.053 per share and an expiration date of October 2, 2031. The options vest over three years in annual installments of 51,666 shares on October 2, 2027, 51,667 shares on October 2, 2028, and 51,667 shares on October 2, 2029, subject to continued service through each vesting date.

Insider Trade Summary

Grant/Award: 155,000 shares

Grant/Award 1 txn

Insider Wilkison William

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	155,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 155,000 contracts (Direct)

Footnotes (1)

1. F1. The options vest over a three -year period in three equal annual installments of 33.33% (51,666 shares on October 2, 2027, 51,667 shares on October 2, 2028 and 51,667 shares on October 2, 2029), subject to the Reporting Person's continued service to the Issuer through each vesting date.

Key Figures

Option shares: 155,000 shares Exercise price: $20.053 per share Vesting period: 3 years +4 more

7 metrics

Option shares 155,000 shares Award to William Wilkison

Exercise price $20.053 per share Option award

Vesting period 3 years Three annual installments, subject to continued service through each vesting date

First vesting installment 51,666 shares October 2, 2027

Second vesting installment 51,667 shares October 2, 2028

Third vesting installment 51,667 shares October 2, 2029

Option expiration date October 2, 2031 Option award

Key Terms

Stock Option (Right to Buy), exercise price, vest, annual installments

4 terms

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

exercise price financial

"the option's exercise price of $20.053 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"The options vest over a three-year period"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual installments financial

"three equal annual installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did VOGX Chief Scientific Officer William Wilkison receive?

William Wilkison received options covering 155,000 shares of Vogenx common stock, with an exercise price of $20.053 per share. The options expire October 2, 2031.

When do VOGX's options for William Wilkison vest?

The options vest in three annual installments: 51,666 shares on October 2, 2027, 51,667 shares on October 2, 2028, and 51,667 shares on October 2, 2029. Vesting is subject to William Wilkison's continued service through each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 04:59 PM Accepted by SEC EDGAR 10/06/2026 - 04:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkison William

(Last) (First) (Middle)

C/O VOGENX, INC

PO BOX 19469

(Street)

RALEIGH NORTH CAROLINA 27619

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vogenx, Inc. [ VOGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$20.053	10/02/2026		A		155,000		(1)	10/02/2031	Common Stock	155,000	$0	155,000	D

Explanation of Responses:

1. The options vest over a three -year period in three equal annual installments of 33.33% (51,666 shares on October 2, 2027, 51,667 shares on October 2, 2028 and 51,667 shares on October 2, 2029), subject to the Reporting Person's continued service to the Issuer through each vesting date.

	/s/ Steven R. Delmar, Attorney-in-Fact for William Wilkison	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)